XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net loss $ (11,858,364) $ (986,939)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 21,900 20,773
(Other income), loan forgiveness (178,250)
Non-cash equity-based compensation expense 8,767,894 187,443
Change in operating assets and liabilities:    
Prepaid expenses and other assets (1,395,366) (181,198)
Royalty obligation (300,000) (125,000)
Accounts payable and accrued expenses 1,583,700 320,826
Net cash used in operating activities (3,358,486) (764,095)
Cash flows from investing activities:    
Purchase of property and equipment (191,034)
Payment of patent costs (48,544) (54,625)
Net cash used in investing activities (239,578) (54,625)
Cash flows from financing activities:    
Proceeds from common stock issuance 23,100,000 754,464
Placement cost (2,548,000)
Proceeds from exercise of options 210,000
Proceeds from SBA - PPP notes payable 178,235
Proceeds from issuance of convertible notes 50,000
Dividends paid (21,232) (32,552)
Principal repayments of notes payable (839)
Net cash provided by financing activities 20,739,929 950,147
Increase (decrease) cash and cash equivalents 17,141,865 131,427
Cash and cash equivalents at beginning of period 10,426,249 2,308,871
Cash and cash equivalents at end of period 27,568,114 2,440,298
Supplementary disclosure of non-cash financing activities:    
Preferred stock conversion to common 2,494,134 50,000
Common stock issued pursuant to antidilutive provisions 4,691,022
Stock issuance, cashless exercise of warrants 74,375
Cash paid during the year for:    
Interest $ 90,630 $ 136,958